We encourage companies
that project change
that project change
t
t@CaixaCR
- RT @3D_Incubator: It's time for the investors! 📷 Mercè Tell @NekkoCapital, Juan Álvarez de Lara @seedandclick y Tania Sagaste (Caixa Capit…
- Thanks for attending to the elevator pitch of the Manufacturing, Energy and Utility sectors hosted by @CaixaCR at… https://t.co/uAB1FZrDaW
- El @4YFN_MWC se consolidada como plataforma global de inversión (vía @exp_catalunya), siendo uno de los eventos de… https://t.co/Bh3M21qtJa
N
News & events
Minoryx Therapeutics appoints Didier Le Normand as Group Chief Financial Officer (CFO) and General Manager of its Belgian subsidiary
12.03.2019
Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that it has appointed Mr. Didier Le Normand as Group CFO as well as General Manager of its recently opened Belgian subsidiary.
Other news See all news »
-
Minoryx Therapeutics receives approval from Spanish Regulatory Agency to initiate phase 2 study in Friedreich’s Ataxia.
28.02.2019
FRAMES trial expected to initiate patient recruitment in upcoming weeks in Spain, Belgium and other European countries. Two Key Opinion Leaders join Minoryx’s ... -
International investors boost Smartvel's capital to increase its growth
12.11.2018
Smartvel, a Spanish startup provider of destination content solutions for the tourism sector, has closed its second round of investment worth 1.05 million dollars... -
AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure
18.10.2018
AELIX Therapeutics S.L. (“AELIX”), a clinical-stage biotechnology company specialized in the discovery and development of immunotherapies for HIV infection, t...